National Medical Care Company announces its Interim Financial results for the Period Ending on 2026-06-30 ( Six Months )

Care Medical reported a record second-quarter net profit of SAR 94 million for 2Q 2026, up 18% year-on-year, though 1H 2026 net profit declined 11% to SAR 146 million due to seasonal softness recorded earlier in the year.
Revenue for 2Q 2026 reached an all-time quarterly high of SAR 456 million, a 15% year-on-year increase driven by a 20% rise in patient volumes to 280,000 and a significant rebound in GOSI referral activity.
Profitability metrics recovered in the second quarter with EBITDA rising 22% year-on-year to SAR 135 million, while gross margins improved to 37.1% supported by a higher-acuity case mix and increased surgical procedure volumes.
The Group is advancing a SAR 1.4 billion investment in the 400-bed Al Narjis Hospital scheduled for 2028, as part of a long-term strategy to add five to eight new facilities by 2032 through greenfield projects and selective acquisitions.

Element List	Current Quarter	Similar quarter for previous year	%Change	Previous Quarter	% Change
Sales/Revenue	456,351	397,872	14.697	387,992	17.618
Gross Profit (Loss)	169,089	147,483	14.649	122,652	37.86
Operational Profit (Loss)	106,754	84,979	25.623	62,983	69.496
Net Profit (Loss) Attributable to Shareholders of the Issuer	93,972	79,941	17.551	52,459	79.134
Total Comprehensive Income Attributable to Shareholders of the Issuer	93,972	79,941	17.551	52,459	79.134
All figures are in (Thousands) Saudi Arabia, Riyals

Element List	Current Period	Similar period for previous year	%Change
Sales/Revenue	844,343	783,193	7.807
Gross Profit (Loss)	291,740	290,461	0.44
Operational Profit (Loss)	169,737	182,175	-6.827
Net Profit (Loss) Attributable to Shareholders of the Issuer	146,431	165,306	-11.418
Total Comprehensive Income Attributable to Shareholders of the Issuer	146,431	165,306	-11.418
Total Shareholders Equity (after Deducting Minority Equity)	1,862,884	1,701,966	9.454
Profit (Loss) per Share	3.28	3.7
All figures are in (Thousands) Saudi Arabia, Riyals

Element List	Amount	Percentage of the capital (%)
Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value	-	-
Accumulated Losses	-	-
All figures are in (Thousands) Saudi Arabia, Riyals

Element List	Explanation
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is	Revenue in the current quarter reached a record high SAR 456.4 million, up 14.7% from the same quarter of last year. The increase was driven by: - A 20% Y-o-Y increase in total patient count. - A strong recovery in key payers resulting in improved payer mix.
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is	Net profit during the current quarter stood at SAR 94 million, representing an increase of 17.6% from the same quarter of the previous year. Net profit margin expanded to 20.6% from 20.1% last year. Net profit growth was primarily driven by: - Strong quarterly revenue, supported by higher patient volumes and improved payor mix. - A 14.7% rise in gross profit, with the gross margin sustained at 37.1%, as strong revenue growth absorbed the increase in cost of revenue during the quarter. - Improved operating profitability, supported by a decline in expected credit loss (ECL) provisions.
The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is	Revenue during the current quarter reached SAR 456.4 million, up 17.6% compared to SAR 388 million in the previous quarter. The increase was supported by: - An 11.3% rise in patient volumes, as activity normalized following the seasonal slowdown associated with Ramadan and Eid in the previous quarter. - A Q-o-Q recovery in payer mix.
The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is	Net profit for the current quarter climbed by 79.1% to SAR 94 million compared to SAR 52.5 million in 1Q 2026. The increase primarily reflects: - Strong revenue growth supported by higher patient activity and favorable payor mix. - A 37.9% increase in gross profit, with the gross margin recovering to 37.1% from 31.6%. - Improved operating profitability, supported by lower ECL provisions in addition to higher operating income during the quarter.
The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is	Revenue in 1H 2026 rose 7.8% year-on-year to SAR 844.3 million. Top-line growth was primarily driven by: - A 15.3% increase in total patient volumes supported by sustained demand across the network. - Sustained momentum across key payor segments. - Broad-based contribution across the Group’s hospital network, led by Al Malaz, with additional gains at Al Rawabi, Al Salam, Al Haram and ReLib.
The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is	Net profit during the first half of the year recorded SAR 146.4 million, down 11.4% compared with the same six-month period of the previous year. Net profit margin recorded 17.3% in 1H 2026 versus 21.1% in 1H 2025. The decline in net profit is attributable to: - A 12.2% increase in cost of revenue, which outpaced revenue growth due to a softer first quarter of 2026. - A 12.7% increase in operating expenses, primarily reflecting a rise in SG&A expenses associated with the Group’s expanded operations. - Higher finance costs during the period.
Statement of the type of external auditor's report	Unmodified conclusion
Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion)	None
Reclassification of Comparison Items	None
Additional Information	-
Attached Documents	Attached Documents